CA2253770A1 - Composition pharmaceutique comprenant du chlorhydrate de bupropion - Google Patents

Composition pharmaceutique comprenant du chlorhydrate de bupropion Download PDF

Info

Publication number
CA2253770A1
CA2253770A1 CA 2253770 CA2253770A CA2253770A1 CA 2253770 A1 CA2253770 A1 CA 2253770A1 CA 2253770 CA2253770 CA 2253770 CA 2253770 A CA2253770 A CA 2253770A CA 2253770 A1 CA2253770 A1 CA 2253770A1
Authority
CA
Canada
Prior art keywords
bupropion hydrochloride
sodium bisulfate
hydrochloride
parts
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2253770
Other languages
English (en)
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2253770 priority Critical patent/CA2253770A1/fr
Priority to PCT/CA1999/001114 priority patent/WO2000030685A1/fr
Priority to AU12559/00A priority patent/AU1255900A/en
Publication of CA2253770A1 publication Critical patent/CA2253770A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA 2253770 1998-11-23 1998-11-23 Composition pharmaceutique comprenant du chlorhydrate de bupropion Abandoned CA2253770A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA 2253770 CA2253770A1 (fr) 1998-11-23 1998-11-23 Composition pharmaceutique comprenant du chlorhydrate de bupropion
PCT/CA1999/001114 WO2000030685A1 (fr) 1998-11-23 1999-11-18 Composition pharmaceutique comportant de l'hydrochlorure de bupropion
AU12559/00A AU1255900A (en) 1998-11-23 1999-11-18 Pharmaceutical composition comprising bupropion hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2253770 CA2253770A1 (fr) 1998-11-23 1998-11-23 Composition pharmaceutique comprenant du chlorhydrate de bupropion

Publications (1)

Publication Number Publication Date
CA2253770A1 true CA2253770A1 (fr) 2000-05-23

Family

ID=4163019

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2253770 Abandoned CA2253770A1 (fr) 1998-11-23 1998-11-23 Composition pharmaceutique comprenant du chlorhydrate de bupropion

Country Status (3)

Country Link
AU (1) AU1255900A (fr)
CA (1) CA2253770A1 (fr)
WO (1) WO2000030685A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8545880B2 (en) 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
US6893660B2 (en) 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
GB0425445D0 (en) * 2004-11-18 2004-12-22 Smithkline Beecham Corp Novel compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69125505D1 (de) * 1990-12-13 1997-05-07 Akzo Nobel Nv Im wesentlichen festes konzentrat, welches ein biozid enthält
US5968553A (en) * 1997-12-30 1999-10-19 American Home Products Corporation Pharmaceutical composition containing bupropion hydrochloride and an inorganic acid stabilizer

Also Published As

Publication number Publication date
AU1255900A (en) 2000-06-13
WO2000030685A1 (fr) 2000-06-02

Similar Documents

Publication Publication Date Title
US6893660B2 (en) Stable pharmaceutical compositions without a stabilizer
BG65011B1 (bg) Усъвършенствани бързоразпадащи се таблетки
CA2404369A1 (fr) Preparations stables d'hormones thyroidiennes et leur procede de fabrication
KR20100015764A (ko) 프레가발린을 포함하는 안정한 약학적 조성물
US6194002B1 (en) Pharmaceutical composition comprising bupropion hydrochloride and fumaric acid
EP1994926B9 (fr) Formulations de valsartan
KR20010071765A (ko) 제약학적 레보타이록신 제제
UA111155C2 (uk) Таблетка, що містить акарбозу і дезінтегрує у роті
US8193226B2 (en) Candesartan cilexetil
US20060165779A1 (en) Novel method stabilizing bupropion hydrochloride tablets
JP5286662B2 (ja) 安中散含有錠剤
EA030758B1 (ru) Фармацевтические составы на основе вилдаглиптина
CA2253770A1 (fr) Composition pharmaceutique comprenant du chlorhydrate de bupropion
HU222497B1 (hu) Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására
AU776522B2 (en) Fosinopril sodium tablet formulation
US6737419B2 (en) Benazepril hydrochloride tablet formulations
US6322812B1 (en) Pharmaceutical forms for the oral administration of mesna
US20060189565A1 (en) Pharmaceutical compositions of ganciclovir
RU2696573C1 (ru) Противомикробный лекарственный препарат в форме таблеток фурацилина с ускоренным высвобождением
US20060165782A1 (en) Solid compositions comprising gabapentin having improved stability
KR100561025B1 (ko) 직접 타정법에 의해 제조되며 보관안정성이 증진된 라미프릴 정제
EP2405899A2 (fr) Préparations de valsartan
CA2442898A1 (fr) Formulation pour comprimes de fosinopril sodique
WO2007060540A1 (fr) Formes galéniques stables d'un antidépresseur
EA002188B1 (ru) Способ получения твёрдой композиции на основе метопролола

Legal Events

Date Code Title Description
FZDE Dead